Results 51 to 60 of about 539 (92)

Pharmacological Characterization of a Novel Complement C3 Inhibitor Antibody Fragment. [PDF]

open access: yesOphthalmol Ther
Jungmichel S   +8 more
europepmc   +1 more source

US Retina Specialists' Preferences for Geographic Atrophy Treatment. [PDF]

open access: yesClin Ophthalmol
Csaky K   +9 more
europepmc   +1 more source

GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration. [PDF]

open access: yesOphthalmol Sci
Jaffe GJ   +13 more
europepmc   +1 more source

Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities. [PDF]

open access: yesMamm Genome
Nimmo J   +7 more
europepmc   +1 more source

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. [PDF]

open access: yesBMJ Open Ophthalmol
Singh RP   +6 more
europepmc   +1 more source

Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The Study of ALK-001 in Geographic Atrophy Randomized Clinical Trial. [PDF]

open access: yesOphthalmol Retina
Boyer DS   +12 more
europepmc   +1 more source

Association of Antibiotic Use and New-Onset ICD Coding of Geographic Atrophy. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Smith SR   +5 more
europepmc   +1 more source

Geographic Atrophy in Age-Related Macular Degeneration. [PDF]

open access: yesDtsch Arztebl Int
Liakopoulos S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy